EMA Endorses New Medicines from Merck, AstraZeneca, Roche, and Corcept Therapeutics

The European Medicines Agency (EMA) has endorsed several new medicines and label expansions for approval. Merck, AstraZeneca, Roche, and Corcept Therapeutics are among the beneficiaries of these EU drug recommendations.

According to an expert panel review, 12 new medicines have been recommended for approval, while 11 label expansions have also been endorsed. This means that patients in the European Union will soon have access to new treatments for various medical conditions.

The EMA's endorsement is a significant milestone for these pharmaceutical companies, as it paves the way for their products to be marketed and sold in the EU.